Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Journey Medical (DERM) Operating Income: 2020-2024

Historic Operating Income for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to -$13.7 million.

  • Journey Medical's Operating Income rose 47.17% to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.5 million, marking a year-over-year increase of 69.50%. This contributed to the annual value of -$13.7 million for FY2024, which is 559.77% down from last year.
  • According to the latest figures from FY2024, Journey Medical's Operating Income is -$13.7 million, which was down 559.77% from -$2.1 million recorded in FY2023.
  • Journey Medical's Operating Income's 5-year high stood at $7.9 million during FY2020, with a 5-year trough of -$34.9 million in FY2021.
  • Moreover, its 3-year median value for Operating Income was -$13.7 million (2024), whereas its average is -$14.4 million.
  • As far as peak fluctuations go, Journey Medical's Operating Income spiked by 92.47% in 2023, and later tumbled by 559.77% in 2024.
  • Yearly analysis of 5 years shows Journey Medical's Operating Income stood at $7.9 million in 2020, then tumbled by 544.29% to -$34.9 million in 2021, then increased by 21.11% to -$27.5 million in 2022, then soared by 92.47% to -$2.1 million in 2023, then plummeted by 559.77% to -$13.7 million in 2024.